Goodwill

9 Months Ended

Sep. 30, 2014

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill Disclosure

10.Goodwill

	September 30,	December 31,
	2014	2013
	$’M	$’M
	____________	____________
Goodwill arising on businesses acquired	2,373.7	624.6
	____________	____________

In the nine months to September 30, 2014 the Company completed the acquisitions of ViroPharma, Lumena,Fibrotech, BIKAM and assets and employees relating to the manufacture of BUCCOLAM which resulted in aggregate goodwill with a preliminary value of $1,773.8 million (see Note 2 for details).

	2014	2013
	$’M	$’M
	____________	____________
As at January 1,	624.6	644.5
Acquisitions	1,773.8	170.3
Goodwill impairment charge related to continuing operations	-	(7.1)
Goodwill impairment charge related to DERMAGRAFT business recorded to discontinued operations	-	(191.8)
Foreign currency translation	(24.7)	5.4
	____________	____________
As at September 30,	2,373.7	621.3
	____________	____________

In the nine months to September 30, 2013 the Company recorded an impairment charge of $198.9 million related to the goodwill allocated to the former RM reporting unit. Following the divestment of the DERMAGRAFT business, $191.8 million of the impairment charge was reclassified to discontinued operations, being the portion of the former RM reporting unit goodwill impairment charge that related to the DERMAGRAFT business.